Oyster Point Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch OYST and buy or sell other stocks, ETFs, and their options commission-free!About OYST
Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease.
CEOJeffrey A. Nau, PhD
CEOJeffrey A. Nau, PhD
Employees—
Employees—
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2015
Founded2015
Employees—
Employees—
OYST Key Statistics
Market cap299.85M
Market cap299.85M
Price-Earnings ratio-1.68
Price-Earnings ratio-1.68
Dividend yield—
Dividend yield—
Average volume498.96K
Average volume498.96K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$16.61
52 Week high$16.61
52 Week low$3.46
52 Week low$3.46
Stock Snapshot
As of today, Oyster Point Pharma(OYST) shares are valued at $11.17. The company's market cap stands at 299.85M, with a P/E ratio of -1.68.
During the trading day, Oyster Point Pharma(OYST) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 498.96K.
The stock's 52-week range extends from a low of $3.46 to a high of $16.61.
The stock's 52-week range extends from a low of $3.46 to a high of $16.61.
People also own
Based on the portfolios of people who own OYST. This list is generated using Robinhood data, and it’s not a recommendation.